{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,19]],"date-time":"2026-01-19T05:31:25Z","timestamp":1768800685412,"version":"3.49.0"},"reference-count":21,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100004320","name":"Shiraz University of Medical Sciences","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004320","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jocn-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Clinical Neuroscience"],"published-print":{"date-parts":[[2023,8]]},"DOI":"10.1016\/j.jocn.2023.06.011","type":"journal-article","created":{"date-parts":[[2023,6,20]],"date-time":"2023-06-20T13:00:34Z","timestamp":1687266034000},"page":"93-96","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["Idiopathic generalized epilepsies: Which seizure type is more difficult to control?"],"prefix":"10.1016","volume":"114","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2598-7601","authenticated-orcid":false,"given":"Ali A.","family":"Asadi-Pooya","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mohsen","family":"Farazdaghi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"6","key":"10.1016\/j.jocn.2023.06.011_b0005","doi-asserted-by":"crossref","first-page":"1475","DOI":"10.1111\/epi.17236","article-title":"ILAE definition of the idiopathic generalized epilepsy syndromes: position statement by the ILAE task force on nosology and definitions","volume":"63","author":"Hirsch","year":"2022","journal-title":"Epilepsia"},{"issue":"1\u20132","key":"10.1016\/j.jocn.2023.06.011_b0010","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/j.jns.2012.10.014","article-title":"A clinical study of syndromes of idiopathic (genetic) generalized epilepsy","volume":"324","author":"Asadi-Pooya","year":"2013","journal-title":"J Neurol Sci"},{"issue":"12","key":"10.1016\/j.jocn.2023.06.011_b0015","doi-asserted-by":"crossref","first-page":"3007","DOI":"10.1111\/epi.17410","article-title":"Drug resistance in idiopathic generalized epilepsies: evidence and concepts","volume":"63","author":"Gesche","year":"2022","journal-title":"Epilepsia"},{"issue":"1","key":"10.1016\/j.jocn.2023.06.011_b0020","doi-asserted-by":"crossref","first-page":"12350","DOI":"10.1038\/s41598-022-16718-x","article-title":"Seizure control in mono- and combination therapy in a cohort of patients with Idiopathic Generalized Epilepsy","volume":"12","author":"Pipek","year":"2022","journal-title":"Sci Rep"},{"issue":"75","key":"10.1016\/j.jocn.2023.06.011_b0025","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3310\/hta25750","article-title":"Lamotrigine versus levetiracetam or zonisamide for focal epilepsy and valproate versus levetiracetam for generalised and unclassified epilepsy: two SANAD II non-inferiority RCTs","volume":"25","author":"Marson","year":"2021","journal-title":"Health Technol Assess"},{"key":"10.1016\/j.jocn.2023.06.011_b0030","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.seizure.2022.03.002","article-title":"Seizure and social outcomes in patients with juvenile myoclonic epilepsy (JME)","volume":"97","author":"Asadi-Pooya","year":"2022","journal-title":"Seizure"},{"issue":"12","key":"10.1016\/j.jocn.2023.06.011_b0035","doi-asserted-by":"crossref","first-page":"3677","DOI":"10.1007\/s10072-020-04490-7","article-title":"Idiopathic (genetic) generalized epilepsies with absences: clinical and electrographic characteristics and seizure outcome","volume":"41","author":"Asadi-Pooya","year":"2020","journal-title":"Neurol Sci"},{"issue":"6","key":"10.1016\/j.jocn.2023.06.011_b0040","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1111\/ane.13227","article-title":"Tonic-clonic seizures in idiopathic generalized epilepsies: prevalence, risk factors, and outcome","volume":"141","author":"Asadi-Pooya","year":"2020","journal-title":"Acta Neurol Scand"},{"issue":"1","key":"10.1016\/j.jocn.2023.06.011_b0045","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1111\/epi.12028","article-title":"Childhood Absence Epilepsy Study Team. Ethosuximide, valproic acid, and lamotrigine in childhood absence epilepsy: initial monotherapy outcomes at 12 months","volume":"54","author":"Glauser","year":"2013","journal-title":"Epilepsia"},{"issue":"5","key":"10.1016\/j.jocn.2023.06.011_b0050","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1097\/WNP.0b013e3181b7f129","article-title":"Clinical features of sudden unexpected death in epilepsy","volume":"26","author":"Asadi-Pooya","year":"2009","journal-title":"J Clin Neurophysiol"},{"issue":"9","key":"10.1016\/j.jocn.2023.06.011_b0055","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1001\/archneur.1996.00550090141020","article-title":"Accidental injury is a serious risk in children with typical absence epilepsy","volume":"53","author":"Wirrell","year":"1996","journal-title":"Arch Neurol"},{"issue":"1","key":"10.1016\/j.jocn.2023.06.011_b0060","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.yebeh.2012.10.019","article-title":"Seizure-related injuries and hospitalizations: self-report data from the 2010 Australian Epilepsy Longitudinal Survey","volume":"26","author":"Bellon","year":"2013","journal-title":"Epilepsy Behav"},{"issue":"7","key":"10.1016\/j.jocn.2023.06.011_b0065","doi-asserted-by":"crossref","first-page":"1006","DOI":"10.1111\/epi.13021","article-title":"Valproate in the treatment of epilepsy in girls and women of childbearing potential","volume":"56","author":"Tomson","year":"2015","journal-title":"Epilepsia"},{"issue":"3","key":"10.1016\/j.jocn.2023.06.011_b0070","first-page":"617","article-title":"Efficacy of levetiracetam, lamotrigine and sodium valproate on seizure attacks and EEG disorders in patients with juvenile myoclonic epilepsy: a double blind randomized clinical trial","volume":"13","author":"Daneshyar","year":"2022","journal-title":"Caspian J Intern Med"},{"key":"10.1016\/j.jocn.2023.06.011_b0075","doi-asserted-by":"crossref","first-page":"107706","DOI":"10.1016\/j.yebeh.2020.107706","article-title":"Response to levetiracetam or lamotrigine in subjects with Juvenile Myoclonic Epilepsy previously treated with valproic acid: a single center retrospective study","volume":"115","author":"Milano","year":"2021","journal-title":"Epilepsy Behav"},{"key":"10.1016\/j.jocn.2023.06.011_b0080","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.eplepsyres.2015.11.012","article-title":"Pharmacological outcomes in juvenile myoclonic epilepsy: support for sodium valproate","volume":"119","author":"Chowdhury","year":"2016","journal-title":"Epilepsy Res"},{"issue":"10282","key":"10.1016\/j.jocn.2023.06.011_b0085","doi-asserted-by":"crossref","first-page":"1375","DOI":"10.1016\/S0140-6736(21)00246-4","article-title":"The SANAD II study of the effectiveness and cost-effectiveness of valproate versus levetiracetam for newly diagnosed generalised and unclassifiable epilepsy: an open-label, non-inferiority, multicentre, phase 4, randomised controlled trial","volume":"397","author":"Marson","year":"2021","journal-title":"Lancet"},{"issue":"3","key":"10.1016\/j.jocn.2023.06.011_b0090","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1007\/s40263-018-00602-2","article-title":"Treatment of juvenile myoclonic epilepsy in patients of child-bearing potential","volume":"33","author":"Serafini","year":"2019","journal-title":"CNS Drugs"},{"issue":"5","key":"10.1016\/j.jocn.2023.06.011_b0095","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1007\/s10072-014-2021-0","article-title":"Epidemiology and clinical manifestations of juvenile myoclonic epilepsy (JME) in Iran","volume":"36","author":"Asadi-Pooya","year":"2015","journal-title":"Neurol Sci"},{"issue":"1","key":"10.1016\/j.jocn.2023.06.011_b0100","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1111\/epi.17104","article-title":"Clinical and EEG factors associated with antiseizure medication resistance in idiopathic generalized epilepsy","volume":"63","author":"Kamitaki","year":"2022","journal-title":"Epilepsia"},{"issue":"2","key":"10.1016\/j.jocn.2023.06.011_b0105","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1002\/epi4.12689","article-title":"How accurately do adult patients report their absence seizures?","volume":"8","author":"Pizarro","year":"2023","journal-title":"Epilepsia Open"}],"container-title":["Journal of Clinical Neuroscience"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0967586823001571?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0967586823001571?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,18]],"date-time":"2025-10-18T21:34:12Z","timestamp":1760823252000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0967586823001571"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,8]]},"references-count":21,"alternative-id":["S0967586823001571"],"URL":"https:\/\/doi.org\/10.1016\/j.jocn.2023.06.011","relation":{},"ISSN":["0967-5868"],"issn-type":[{"value":"0967-5868","type":"print"}],"subject":[],"published":{"date-parts":[[2023,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Idiopathic generalized epilepsies: Which seizure type is more difficult to control?","name":"articletitle","label":"Article Title"},{"value":"Journal of Clinical Neuroscience","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jocn.2023.06.011","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}